(Q33941370)

30 July 2017

1 reference

title

JAK-STAT signaling activated by Abl oncogenes (English)

1 reference

30 July 2017

N N Danial

1 reference

30 July 2017

P Rothman

series ordinal

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 May 2000

1 reference

30 July 2017

1 reference

30 July 2017

1 reference

30 July 2017

1 reference

30 July 2017

page(s)

2523-2531

1 reference

Tyrosyl phosphorylation and DNA binding activity of signal transducers and activators of transcription (STAT) proteins in hematopoietic cell lines transformed by Bcr/Abl

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203484

Abrogation of interleukin-3 dependence of myeloid cells by the v-src oncogene requires SH2 and SH3 domains which specify activation of STATs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203484

An active v-abl protein tyrosine kinase blocks immunoglobulin light-chain gene rearrangement

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203484

Impaired immunoglobulin gene rearrangement in mice lacking the IL-7 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203484

Direct interaction of Jak1 and v-Abl is required for v-Abl-induced activation of STATs and proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203484

Jak-STAT signaling induced by the v-abl oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203484

Increased sensitivity to apoptotic stimuli in c-abl-deficient progenitor B-cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203484

Lymphoproliferative disorders in IL-7 transgenic mice: expansion of immature B cells which retain macrophage potential.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203484

Latent membrane protein 1 of Epstein-Barr virus interacts with JAK3 and activates STAT proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203484

Oligomerization of the ABL tyrosine kinase by the Ets protein TEL in human leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203484

Protein-tyrosine phosphatase Shp-1 is a negative regulator of IL-4- and IL-13-dependent signal transduction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203484

Bone Marrow B Lymphocyte Development in c-abl-Deficient Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203484

Interaction of abl and raf with IL-7 signaling pathway and transformation of pre-B cells from resistant mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203484

Negative regulators of cytokine signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203484

P210 and P190(BCR/ABL) induce the tyrosine phosphorylation and DNA binding activity of multiple specific STAT family members

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203484

The amphiphysin-like protein 1 (ALP1) interacts functionally with the cABL tyrosine kinase and may play a role in cytoskeletal regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203484

The Elongin BC complex interacts with the conserved SOCS-box motif present in members of the SOCS, ras, WD-40 repeat, and ankyrin repeat families

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203484

Cell cycle-regulated binding of c-Abl tyrosine kinase to DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203484

A novel human gene closely related to the abl proto-oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203484

Abl tyrosine protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203484

The P190, P210, and P230 forms of the BCR/ABL oncogene induce a similar chronic myeloid leukemia-like syndrome in mice but have different lymphoid leukemogenic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203484

Mutation in the Jak kinase JH2 domain hyperactivates Drosophila and mammalian Jak-Stat pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203484

Effect of Bcr sequences on the cellular function of the Bcr-Abl oncoprotein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203484

Activation of tyrosinase kinase and microfilament-binding functions of c-abl by bcr sequences in bcr/abl fusion proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203484

Positive and negative selection events during B lymphopoiesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203484

Inactivation of erythropoietin receptor function by point mutations in a region having homology with other cytokine receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203484

Comparison of IL-13- and IL-4-induced signaling in EBV-immortalized human B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203484

Three distinct domains of SSI-1/SOCS-1/JAB protein are required for its suppression of interleukin 6 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203484

Protein tyrosine phosphatases in signal transduction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203484

Signal transducer and activator of transcription (STAT)5 activation by BCR/ABL is dependent on intact Src homology (SH)3 and SH2 domains of BCR/ABL and is required for leukemogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203484

Association of CrkL with STAT5 in hematopoietic cells stimulated by granulocyte-macrophage colony-stimulating factor or erythropoietin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203484

Interleukin-7 retroviruses transform pre-B cells by an autocrine mechanism not evident in Abelson murine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203484

Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203484

The Bcr-Abl leukemia oncogene activates Jun kinase and requires Jun for transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203484

Dominant negative MYC blocks transformation by ABL oncogenes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203484

Genetic requirement for Ras in the transformation of fibroblasts and hematopoietic cells by the Bcr-Abl oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203484

Transformation of hematopoietic cell lines to growth-factor independence and induction of a fatal myelo- and lymphoproliferative disease in mice by retrovirally transduced TEL/JAK2 fusion genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203484

The STAT family of proteins in cytokine signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203484

Transformation of hematopoietic cells by BCR/ABL requires activation of a PI-3k/Akt-dependent pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203484

Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203484

The mouse type IV c-abl gene product is a nuclear protein, and activation of transforming ability is associated with cytoplasmic localization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203484

The COOH terminus of the c-Abl tyrosine kinase contains distinct F- and G-actin binding domains with bundling activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203484

Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203484

The mouse c-abl locus: molecular cloning and characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203484

The Src family kinase Hck interacts with Bcr-Abl by a kinase-independent mechanism and phosphorylates the Grb2-binding site of Bcr

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203484

Cell cycle control of c-kit+IL-7R+ B precursor cells by two distinct signals derived from IL-7 receptor and c-kit in a fully defined medium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203484

Molecular characterization of specific interactions between SHP-2 phosphatase and JAK tyrosine kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203484

Hyperexpression of interleukin-7 is not necessary or sufficient for transformation of a pre-B lymphoid cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203484

Signaling pathways activated by oncogenic forms of Abl tyrosine kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203484

Dominant negative variants of the SHP-2 tyrosine phosphatase inhibit prolactin activation of Jak2 (janus kinase 2) and induction of Stat5 (signal transducer and activator of transcription 5)-dependent transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203484

7 January 2021

c-Abl kinase regulates the protein binding activity of c-Crk

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203484

7 January 2021

The TEL gene and human leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203484

7 January 2021

The Drosophila Tumorous-lethal hematopoietic oncogene is a dominant mutation in the hopscotch locus.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203484

7 January 2021

Activation of a Drosophila Janus kinase (JAK) causes hematopoietic neoplasia and developmental defects.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203484

7 January 2021

Lack of constitutive activation of Janus kinases and signal transduction and activation of transcription factors in Philadelphia chromosome-positive acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203484

7 January 2021

Regulation of angiotensin II-induced JAK2 tyrosine phosphorylation: roles of SHP-1 and SHP-2

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203484

7 January 2021

Sequences of the A-MuLV protein needed for fibroblast and lymphoid cell transformation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203484

7 January 2021

Mice homozygous for the ablm1 mutation show poor viability and depletion of selected B and T cell populations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203484

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1203484

1 reference

Dimensions Publication ID

30 July 2017

1005311964

0 references

1 reference